A detailed history of Silvant Capital Management LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Silvant Capital Management LLC holds 17,231 shares of VKTX stock, worth $906,178. This represents 0.05% of its overall portfolio holdings.

Number of Shares
17,231
Previous 17,231 -0.0%
Holding current value
$906,178
Previous $913,000 19.39%
% of portfolio
0.05%
Previous 0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$17.4 - $94.5 $299,819 - $1.63 Million
17,231 New
17,231 $1.41 Million

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.03B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Silvant Capital Management LLC Portfolio

Follow Silvant Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvant Capital Management LLC with notifications on news.